Fisher Funds Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.78M Sell
24,245
-1,405
-5% -$481K 0.25% 93
2026
Q1
$9.02M Sell
25,650
-4,191
-14% -$1.49M 0.26% 92
2025
Q4
$9.78M Hold
29,841
0.25% 87
2025
Q3
$8.42M Hold
29,841
0.22% 93
2025
Q2
$8.33M Sell
29,841
-3,315
-10% -$939K 0.2% 89
2025
Q1
$10.3M Hold
33,156
0.25% 81
2024
Q4
$8.65M Buy
+33,156
New +$9.84M 0.21% 85

Other funds holding AMGN

Fisher Funds Management's AMGN Position: Q2 2026 in Review

Fisher Funds Management reduced its Amgen (AMGN) stake by 5.5% in Q2 2026, selling an estimated $481K and leaving 24,245 shares worth $8.78M. The position accounts for 0.25% of the portfolio, ranked #93.

Fisher Funds Management first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $10.3M in Q1 2025. 577 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Fisher Funds Management held 24,245 shares of Amgen worth $8.78M as of Q2 2026.
  • Fisher Funds Management sold 1,405 Amgen shares in Q2 2026, an estimated $481K.
  • Amgen made up 0.25% of Fisher Funds Management's portfolio in Q2 2026, its #93 holding.
  • Fisher Funds Management first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • Fisher Funds Management's Amgen position peaked at $10.3M in Q1 2025.
  • 577 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Fisher Funds Management's 13F filing for Q2 2026, filed 14 Jul 2026.